Bioveta further strengthens its position on the Latin American markets

Homepage News What´s new? Bioveta further strengthens its position on the Latin American markets

12.8.2025

In the last week of July, we together with our business partner, the Venezuelan company Seprogan, officially launched new lines of vaccines for dogs (Biocan) and cats (Biofel) in Venezuela.

The launch of sales of our products was supported by a series of professional seminars that took place in four major Venezuelan cities – Barquisimeto, Valencia, Maracay and Caracas. Each of these seminars was attended by approximately one hundred local veterinarians, which confirms the strong interest of the professional public in high-quality European products and modern approaches to the prevention of infectious diseases.

The individual events were also attended by MVDr. Alberto Velasquez, Bioveta’s regional director for Latin America, who joined all seminars via live video connection. The professional part, focused on the principles of immunological protection of animals, was always led by a local expert, an opinion leader in the field of veterinary immunology and vaccinology.

We are pleased to announce that Bioveta's vaccines for dogs and cats have also been successfully launched in the past in Mexico, Colombia and Brazil, the two largest countries in South America. The products have quickly gained the trust of veterinarians and breeders due to the quality, safety and reliable protection they provide.

The prospect for 2026 is to expand our operations to medium-sized countries such as Chile and Bolivia. Bioveta is thus becoming an established company on the South American continent.